Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

6.21
Delayed Data
As of May 26
 -0.10 / -1.58%
Today’s Change
2.56
Today|||52-Week Range
19.99
+11.29%
Year-to-Date
2 Promising Biopharmas Reach Key Junctures
May 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.31
Today’s open6.34
Day’s range6.12 - 6.35
Volume381,119
Average volume (3 months)794,482
Market cap$225.5M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-88.46%
Earnings growth (this year)+31.73%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-11.60%
P/E ratioNM
Price/Sales282.75
Price/Book2.17

Competitors

 Today’s
change
Today’s
% change
FLKSFlex Pharma Inc-0.23-1.82%
ABUSArbutus Biopharma Co...+0.06+1.43%
CMRXChimerix Inc-0.03-0.62%
MNOVMediciNova Inc+0.04+0.60%
Data as of 05/26/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$678.0K
Annual profit (last year)-$84.1M
Net profit margin-12,397.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
CFO, Treasurer &
Head-Investor Relations
Craig A. Tooman
Corporate headquarters
Leawood, Kansas

Forecasts

Partner Offers

Search for Jobs